News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

In the UK, Pathologists Are Watching Phase II of a Clinical Trial for a Breathalyzer System That Uses Only a Breath Specimen to Diagnose Lung Cancer

If the clinical study validates this patient-friendly, non-invasive approach to diagnosing lung cancer, it could eventually mean fewer referrals of tissue biopsies to medical laboratories

For almost a decade, pathologists have seen a regular stream of news stories about technologies that utilize a sample of human breath to diagnose a disease or health condition. Now comes news that just such a diagnostic test for lung cancer is beginning clinical trials in the United Kingdom.

The clinical trials will evaluate breathalyzer technology developed by Engineer Billy Boyle, M.S., Co-founder and President of Operations at Cambridge-based Owlstone Ltd.. The clinical trials of this new breathalyzer technology to detect lung cancer are taking place at two National Health Service (NHS) hospitals: University Hospitals of Leicester and Cambridge’s Papworth Hospital in the United Kingdom.

The reason why so much research is happening in this field will be familiar to clinical laboratory managers and pathologists. Use of volatile organic compound (VOC) biomarkers in breath to diagnose disease is an ideal concept because it is convenient, non-invasive, and well tolerated by patients. However, until the start of this clinical study, researchers have explored the potential of this diagnostic approach for some time, but with limited success. (more…)

Medical Laboratory Leaders Gather in the United Kingdom to Address Challenges of Shrinking Lab Budgets and Need to Upgrade Quality Assurance Performance

Nation’s healthcare system is in the midst of major clinical, organizational, and financial reforms—many of which require immediate responses by pathology laboratories

BIRMINGHAM, England—Two major challenges in laboratory medicine were front and center this week when medical laboratory, a professionals and histopathologists gathered here in the United Kingdom (UK) for the eleventh annual Frontiers in Laboratory Medicine (FiLM).

One challenge is how to improve the quality of lab testing services and demonstrate value to payers. The other challenge is how medical laboratories in the UK  can cope with shrinking budgets for medical laboratories. (more…)

French Court of Auditors Call for 7.5% Cut in Medical Laboratory Fees to Help Balance the Nation’s Healthcare Budget

If enacted, this fee cut is predicted to cost medical laboratories €316M Annually and eliminate about 8,000 jobs in that nation

Clinical laboratories here in the United States are not alone in their struggle maintain quality as declining reimbursements from private and government health programs force cost-cutting measures. In France, medical laboratories have learned that they will soon see a sizeable cut in reimbursement paid to them for lab testing services.

This summer, France’s Cour des comptes (French Court of Auditors) called for cutting tariffs to medical laboratories by 7.5%, according to a report published by The Connexion.

Price Cuts Justified by Overutilization of Medical Laboratory Tests (more…)

Pathology Laboratories in the United Kingdom Are Bracing for New Payment Methods and More Medical Laboratory Consolidation

Speakers lay out clear path for medical laboratories at the 11th Annual Frontiers in Laboratory Medicine

DATELINE: Birmingham, England—Pathology laboratories in the United Kingdom are undergoing change at an unprecedented pace. The impetus for change comes from both a shift in how medical laboratories will be paid, as well as the regional integration of medical laboratory services, which is occurring in communities throughout the nation.

These two powerful trends were given strong emphasis by speakers during the first day of the 11th Annual Frontiers in Laboratory Medicine (FiLM) conference, Jan. 29 and 30. What makes these two trends quite profound is that one trend revises—in a significant manner—how pathology laboratories will be paid going forward. In turn, that affects the ability of individual medical laboratories to access needed capital to acquire new instruments and new diagnostic technologies. (more…)

Pathology Laboratories in the United Kingdom to Be Challenged by New Reimbursement Models and the NHS’ Latest Call for Faster Innovation

Pathologists and medical laboratory managers will take up these issues at the upcoming Frontiers in Laboratory Medicine Conference in Birmingham, England on January 29-30, 2013

Medical laboratory testing in the United Kingdom is experiencing change at an accelerating rate. These changes reflect ongoing reforms within the National Health System (NHS), which is itself dealing with increased demand for healthcare services in the face of limited budgets.

That means providers in the United Kingdom—including pathology laboratories—are being asked to deliver more clinical services even as budgets are held constant or even reduced. There are also calls for all providers of clinical services to become more innovative in ways that improve the quality of patient services while reducing the overall cost of care. (more…)

;